🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07181902
Starting soon Observational

Postoperative Recovery Quality After Cesarean Section: Comparing Erector Spinae and Retrolaminar Blocks Using Turkish Version of the Obstetric Quality-of-Recovery Score in a Turkish Cohort (ObsQoR-11T)

NCT07181902 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-10-01
Last updated
2025-09-30

Condition(s) studied

Postoperative Pain Management

Investigational drug(s) / intervention(s)

Erector Spinae Plane Block (ESP)Retrolaminar Block (RLB)

Erector Spinae Plane Block (ESP): Ultrasound-guided ESP block performed immediately after cesarean section at T9 level using 20 mL of 0.25% bupivacaine. Standard perioperative care and analgesia protocols are applied.

Retrolaminar Block (RLB): Ultrasound-guided Retrolaminar Block performed immediately after cesarean section at T9 level using 20 mL of 0.25% bupivacaine. Standard perioperative care and analgesia protocols are applied.

Study summary

Study Design This retrospective observational study aims to evaluate and compare the effects of two regional anesthesia techniques, Erector Spinae Plane (ESP) block and Retrolaminar Block (RLB), on postoperative recovery quality in women undergoing elective cesarean section (CS). Postoperative pain after CS is common, particularly in the first 24-72 hours, and can affect mobility, breastfeeding, and overall well-being. Effective pain management is therefore critical for both patient comfort and maternal-infant bonding.

Participants and Methods Medical records of adult women aged 18-45 years, with a singleton pregnancy at ≥37 weeks, who underwent elective CS under spinal anesthesia in our clinic, were retrospectively reviewed. Patients who had received either ESP or RLB immediately after surgery were included. Both blocks had been performed under ultrasound guidance at the T9 level using 20 mL of 0.25% bupivacaine, according to institutional practice. Standard perioperative care and analgesia protocols were applied to all patients.

Outcomes The primary outcome was postoperative recovery quality, assessed 24 hours after surgery using the Turkish version of the Obstetric Quality-of-Recovery Score (ObsQoR-11T), a validated tool addressing physical, emotional, and functional aspects of recovery. Secondary outcomes included postoperative pain intensity (Visual Analog Scale), opioid consumption, adverse events, and patient satisfaction, as documented in patient files.

Conclusion This retrospective study will provide evidence on which block technique more effectively improves recovery quality after CS and may help optimize postoperative analgesia strategies in Turkish obstetric populations.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria * Women aged 18-45 years, scheduled for elective cesarean delivery under spinal anesthesia. * Gestational age ≥37 weeks, singleton pregnancy. * Undergoing either ESP or RLB for postoperative analgesia. * ASA Physical Status II-III. * Ability to understand and complete ObsQoR-11T questionnaire. * Provided written informed consent prior to participation. Exclusion Criteria * Emergency cesarean delivery. * Multiple pregnancy, preterm delivery (\<37 weeks), * Severe maternal or obstetric complications (e.g., preeclampsia, placenta previa, placenta accreta spectrum), regardless of urgency. * BMI ≥40 kg/m² * Significant systemic diseases (e.g., severe cardiac, respiratory, renal, or hepatic disease). * Fetal or placental anomalies. * History of chronic pain syndromes, opioid dependence, or long-term analgesic use. * Neurological, psychiatric, or cognitive disorders that may interfere with pain perception or questionnaire completion. * Patients who declined participation or did not provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Elazığ Fethi Sekin City Hospital Elâzığ Seçiniz

More Elazıg Fethi Sekin Sehir Hastanesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07181902 on ClinicalTrials.gov ↗ ← All trials in Turkey